Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Ultrasound in Medicine & Biology
|
January 1, 1997
Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle
A L Strauss, K D Beller
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
December 1, 1996
[Duplex ultrasound with echo contrast media]
A L Strauss, K D Beller
Ultrasound in Medicine & Biology
|
July 22, 1999
Persistent opacification of the left ventricle and myocardium with a new echo contrast agent
A L Strauss, K D Beller
Basic Research in Cardiology
|
January 1, 1996
Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity
R Leischik, K D Beller, R Erbel
Academic Radiology
|
August 1, 1996
BY963: a sonographic contrast medium
P Solleder, K D Beller, R Linder
Ultrasound in Medicine & Biology
|
January 1, 1996
Pharmacokinetic studies of different echo-contrast agents in the cerebral circulation of dogs
G Seidel, K D Beller, M Kaps
Arzneimittel-Forschung
|
November 11, 1999
[The effect of carvedilol on contrast echocardiography in comparison to metoprolol in conscious dogs]
K D Beller, F Diedrich, G Sponer
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
July 17, 1998
Administration of modified spherosome suspension (BY963) leads to an increase of acoustic impedance in dog brain tissue
G Seidel, K D Beller, M Kaps
The American Journal of Cardiology
|
August 15, 1989
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil
N Kolassa, K D Beller, K H Sanders
The American Journal of Cardiology
|
February 2, 1989
Evidence for the interaction of urapidil with 5-HT1A receptors in the brain leading to a decrease in blood pressure
N Kolassa, K D Beller, K H Sanders
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Ultrasound in Medicine & Biology
|
January 1, 1997
Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle
A L Strauss, K D Beller
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
December 1, 1996
[Duplex ultrasound with echo contrast media]
A L Strauss, K D Beller
Ultrasound in Medicine & Biology
|
July 22, 1999
Persistent opacification of the left ventricle and myocardium with a new echo contrast agent
A L Strauss, K D Beller
Basic Research in Cardiology
|
January 1, 1996
Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity
R Leischik, K D Beller, R Erbel
Academic Radiology
|
August 1, 1996
BY963: a sonographic contrast medium
P Solleder, K D Beller, R Linder
Ultrasound in Medicine & Biology
|
January 1, 1996
Pharmacokinetic studies of different echo-contrast agents in the cerebral circulation of dogs
G Seidel, K D Beller, M Kaps
Arzneimittel-Forschung
|
November 11, 1999
[The effect of carvedilol on contrast echocardiography in comparison to metoprolol in conscious dogs]
K D Beller, F Diedrich, G Sponer
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
July 17, 1998
Administration of modified spherosome suspension (BY963) leads to an increase of acoustic impedance in dog brain tissue
G Seidel, K D Beller, M Kaps
The American Journal of Cardiology
|
August 15, 1989
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil
N Kolassa, K D Beller, K H Sanders
The American Journal of Cardiology
|
February 2, 1989
Evidence for the interaction of urapidil with 5-HT1A receptors in the brain leading to a decrease in blood pressure
N Kolassa, K D Beller, K H Sanders
Page
of 2